RADX Annual Operating Profit
-$24.01 M
-$790.40 K-3.40%
01 June 2024
Summary:
As of January 30, 2025, RADX annual operaing income is -$24.01 million, with the most recent change of -$790.40 thousand (-3.40%) on June 1, 2024. During the last 3 years, it has fallen by -$9.57 million (-66.24%). RADX annual operating profit is now -66.24% below its all-time high of -$14.44 million, reached on June 1, 2022.RADX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.4% | - | - |
3 y3 years | -66.2% | - | - |
5 y5 years | -66.2% | - | - |
RADX Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -66.2% | at low | ||||
5 y | 5-year | -66.2% | at low | ||||
alltime | all time | -66.2% | at low |
Radiopharm Theranostics Limited Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | -$24.01 M(+3.4%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | -$23.22 M(+60.8%) | - | - |
June 2022 | -$14.44 M | - | - |
FAQ
- What is Radiopharm Theranostics Limited annual operaing income?
- What is the all time high annual operating profit for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual operating profit year-on-year change?
What is Radiopharm Theranostics Limited annual operaing income?
The current annual operating profit of RADX is -$24.01 M
What is the all time high annual operating profit for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual operaing income is -$14.44 M
What is Radiopharm Theranostics Limited annual operating profit year-on-year change?
Over the past year, RADX annual operaing income has changed by -$790.40 K (-3.40%)